相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
Myriam Calle Rubio et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2023)
Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD
Marc Miravitlles et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2022)
Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study
Marc Miravitlles et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2021)
Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study
Marc Miravitlles et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2021)
Treatment Pathways Before and After Triple Therapy in COPD A Population-based Study in Primary Care in Spain
Monica Monteagudo et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2021)
GesEPOC 2021: One More Step Towards Personalized Treatment of COPD
Marc Miravitlles et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2021)
Plasma Eosinophil Count and Patient-Centered Events in Chronic Obstructive Pulmonary Disease in Real-Life Clinical Practice
Rafael Golpe et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2020)
Evaluation of Changes in Control Status in COPD An Opportunity for Early Intervention
Juan Jose Soler-Cataluna et al.
CHEST (2020)
The Clinical Implications of Triple Therapy in Fixed-Dose Combination in COPD: From the Trial to the Patient
Jose Luis Lopez-Campos et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2020)
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
Dave Singh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline
James D. Chalmers et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prognostic Validation Using GesEPOC 2017 Severity Criteria
Carlos Cabrera Lopez et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2019)
Risk Stratification in Chronic Obstructive Pulmonary Disease. Can the Spanish Guidelines be Improved?
Rafael Golpe et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2018)
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
Alberto Papi et al.
LANCET (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Risk Stratification in Chronic Obstructive Pulmonary Disease. Can the Spanish Guidelines be Improved?
Rafael Golpe et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2018)
Depressive status explains a significant amount of the variance in COPD assessment test (CAT) scores
Marc Miravitlles et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit
Jose Luis Lopez-Campos et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
Mario Cazzola et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Initiation of triple therapy maintenance treatment among patients with COPD in the US
Jason C. Simeone et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study
Myriam Calle Rubio et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
Douglas Mapel et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
James D. Chalmers et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2017)
Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Ian D. Pavord et al.
THORAX (2016)
Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort
Borja G. Cosio et al.
CHEST (2016)
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
Dave Singh et al.
LANCET (2016)
Clinical Audits in Outpatient Clinics for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Workflow
Jose Luis Lopez-Campos et al.
PLOS ONE (2015)
Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?
Pierre-Regis Burgel et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD
Maria Papala et al.
PRIMARY CARE RESPIRATORY JOURNAL (2013)
A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)
Marc Miravitlles et al.
PRIMARY CARE RESPIRATORY JOURNAL (2013)
A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol
JF Donohue et al.
CHEST (2002)
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
R Casaburi et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
分享论文
